Search

everythingexperts & clinicslearnfaqsresearchcommunity

for

Search:↓

This report reviews familial cases of aplasia cutis of the scalp, noting large irregular defects at the vertex or anterior along the sagittal suture in six families.

This study found an association between vertex baldness and prostate cancer, especially for high-grade tumors in men aged 60-69, suggesting a possible shared androgen pathway.

This article discusses the genetic and hormonal factors contributing to male pattern hair loss but reports no new experimental results.

In this case study, Ayurvedic management including Viddhakarma and Nilibhringadi Taila led to significant hair regrowth and improved hair quality in a 37-year-old man with androgenetic alopecia, without adverse effects.

This study found that hair from the vertex posterior is a reliable sampling region for detecting zolpidem intake, showing consistent drug concentration and peak position compared to other scalp regions.

This study found that mosaic mutations in the CARD14 gene are linked to inflammatory linear verrucous epidermal naevus in two patients, who experienced significant improvement with the IL12/IL23 inhibitor Ustekinumab.

This article previews a Journal of Investigative Dermatology quiz on diagnosing male androgenetic alopecia and offers no new research results.

This article discusses androgenetic alopecia, including its prevalence, different patterns in men and women, and variations among races, without providing new clinical findings.

This study found that applying a 1% BOI lotion improved hair density and thickness in patients with mild pattern hair loss over six months.

Most older adults experience pattern hair loss due to shrinking hair follicles, with men and women showing different balding patterns.

In this study, young Thai men with androgenetic alopecia reported poorer quality of life compared to older men, as indicated by higher DLQI scores.

In this case study, a 20-year-old man experienced progressive hair loss starting as a localized patch on the vertex of his scalp, eventually spreading in a curvilinear pattern to the sides and back.

This study found no difference in male pattern baldness between patients with benign prostate hyperplasia and prostate cancer, and no correlation with serum androgen levels.

This article reviews the causes and pattern of androgenetic alopecia and reports no new research findings.

The document concludes that a unique target-like hair regrowth pattern in alopecia areata may be more common than thought and should be properly identified.

This study found that oral minoxidil 5 mg daily significantly improves hair growth in men with male pattern hair loss, demonstrating safety with minor side effects such as hypertrichosis and pedal edema.

Long-term diabetes is linked to lower prostate cancer risk.

This review discusses the treatment options for male androgenetic alopecia, including FDA-approved therapies and new possibilities, but reports no new clinical results.

This review discusses male androgenetic alopecia treatments, noting that topical minoxidil and oral finasteride are FDA-approved and require continuous use to maintain hair retention effects, but reports no new clinical results.

This study reported that robotic-assisted and specialized tool techniques for FUE hair transplantation have specific indications for different hair types and scalp areas, particularly benefiting patients undergoing multiple transplants.

A woman developed rare, unexplained curly hair on her scalp and eyelashes.

This study found that finasteride (1 mg) significantly increased hair growth in all scalp regions affected by male pattern hair loss over 24 months in men aged 18 to 60, with more pronounced effects in younger men.

This study found that an adapted version of the Hamilton-Norwood classification improves reliability in assessing pattern hair loss and could aid population studies examining its association with cardiovascular disease.

Minoxidil promotes hair growth in male pattern baldness.

Young men with male pattern baldness lose hair density over time without treatment.

Minoxidil effectively regrows hair in male pattern baldness.

This study found that 1% and 2% topical minoxidil solutions resulted in clinically noticeable hair growth compared to lower doses or placebo in men with male pattern baldness.

This article is a letter to the editor about fibrosing alopecia in a pattern distribution and reports no new research findings.

Over 50% of women over 50 experience hair loss, with minoxidil being the only proven effective treatment.

This study reported higher dihydrotestosterone and testosterone levels in balding Korean and Caucasian subjects compared to non-balding controls, with variations suggesting racial differences in androgen metabolism.